AI Software & Applications
A broad cybersecurity vendor — network, cloud, and security operations — increasingly driven by AI.
{'verdict': 'No signals sit in the elevated band. Ranks 47th of 68 on composite fragility (F\xa030.75), below CrowdStrike and Intuit.', 'as_of': '2026-07-11', 'source': 'engine-restatement (T1)', 'snapshot': {'composite_f': 30.75, 'n_elevated': 0, 'convergence': 'watch', 'rank': 47, 'elevated': []}}
'You stopped disclosing billings after the February 2024 earnings call that triggered a 28% single-day stock crash. Organic NGS ARR growth decelerated from 40% in Q1 FY2025 to 29% in Q1 FY2026. Now Q3 FY2026 shows plus 56% NGS ARR growth. Your own sheet flags that number as inorganic — CyberArk's ARR consolidated onto your books after the February 11, 2026 close. How much of that 56% is the platfo
Billings no longer disclosed after FY2024 controversy; absent from Q1 and Q2 FY2026 press releases and 10-Qs (confirmed in sheet). Feb 2024 earnings triggered a "28% single-day stock crash" (per sheet). Organic NGS ARR: Q1 FY25 $4.5B (+40%); Q4 FY25 $5.58B (+32%); Q1 FY26 $5.9B (+29%); Q2 FY26 $6.3B (+33%) — all PRIMARY (PANW quarterly EX-99.1 and 10-Qs). CyberArk closed 2026-02-11 (~$25B, PANW 8-K — PRIMARY). Post-close Q3 FY26 NGS ARR growth +56% is INORGANIC (CyberArk identity-security ARR consolidating). FY26 NGS ARR guidance $8.52–8.62B (+53–54%) also INORGANIC. Organic-only Q3 FY26+ NGS ARR: NOT SOURCED.
'You paid approximately $25 billion for CyberArk. Management guided it will be dilutive to FCF per share through FY2027 and accretive only in FY2028. You made the largest acquisition in company history in a window where organic NGS ARR growth was already decelerating and you had just stopped disclosing your key demand-timing metric. What does the organic platformization story look like without Cyb
CyberArk: ~$25B, closed 2026-02-11 (PANW 8-K; original 8-K + S-4 2025-07-30/2025-10-22 — PRIMARY). Accretive to FCF/share by FY2028; dilutive FY2026–2027. Last organic NGS ARR data point before close: Q2 FY26 $6.3B (+33% YoY). Billings proxy (COMPUTED from deferred-revenue moves, not filed): Q1 FY26 ~$1.95B; Q2 FY26 ~$2.79B. Detailed CyberArk financing/synergy terms: NOT SOURCED (S-4, 2025-10-22, not fully extracted). Organic-only NGS ARR trajectory post-acquisition: NOT SOURCED.
'Nikesh Arora bought 68,085 shares at $146.87 average in March 2026 — roughly $10 million of his own money — and that is the strongest counter-signal in this dataset, this sheet concedes it. But the NGS ARR to revenue gap is 17 points (ARR +32%, revenue +15%), billings is unverifiable, and inorganic ARR inflates every headline from Q3 FY2026 forward. If Arora is right that the stock was cheap, wha
Arora purchase: 68,085 shares at $146.874 avg = ~$10.0M, code P (open-market purchase), filed 2026-03-27 (SEC Form 4 CIK 1327567 — PRIMARY). Post-transaction: 343,394 direct + 32,010 + 726,542 indirect shares. NGS ARR FY2025: $5.58B (+32% YoY); revenue FY2025: $9,221.5M (+15% YoY) — 17-point gap (PANW Q4 FY2025 EX-99.1 — PRIMARY). Mechanism per sheet: customers given subsidized platform access build dependencies, then convert to paid subscriptions — revenue follows NGS ARR by 6–18 months. RPO $15.8B (+24% YoY, Q4 FY2025 EX-99.1 — PRIMARY) supports this as contracted future revenue. Arora direct holdings post-purchase: 343,394 shares (PRIMARY).